within Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AG06_Tiagabine;

model Tiagabine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 2.138888888888889e-06,
    adminDuration = 600,
    adminMass = 30 / 1000000,
    adminCount = 1,
    Vd = 0.0009,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Tiagabine</td></tr><tr><td>ATC code:</td><td>N03AG06</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>30</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.9</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.11</td><td>L/hr/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Tiagabine is an anticonvulsant medication primarily used as an adjunctive therapy in the treatment of partial seizures in epilepsy. It works by inhibiting the reuptake of gamma-aminobutyric acid (GABA) in the brain, thereby increasing the availability of this inhibitory neurotransmitter. Tiagabine is approved for clinical use and is typically administered orally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers receiving single oral doses.</p><h4>References</h4><ol><li><p>Jacob, S, &amp; Nair, AB (2016). An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. <i>Drugs in R&amp;D</i> 16(4) 303–316. DOI:<a href=\"https://doi.org/10.1007/s40268-016-0148-6\">10.1007/s40268-016-0148-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27766590/\">https://pubmed.ncbi.nlm.nih.gov/27766590</a></p></li><li><p>Perucca, E (2005). Pharmacokinetic variability of new antiepileptic drugs at different ages. <i>Therapeutic drug monitoring</i> 27(6) 714–717. DOI:<a href=\"https://doi.org/10.1097/01.ftd.0000179847.37965.4e\">10.1097/01.ftd.0000179847.37965.4e</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16404801/\">https://pubmed.ncbi.nlm.nih.gov/16404801</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N03AG06 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Tiagabine;
